LDX lumos diagnostics holdings limited

The re-rate journey, page-337

  1. 1,747 Posts.
    lightbulb Created with Sketch. 219
    To be clear, there is no cusp of product in customers hands. It is already.

    Revenue from Viradx was advised pre Christmas as an indication.

    Is is now in ramp up stage to get more of it out there.

    The price right now is ridiculously low for what stage they are at.

    FDA approval put his at .17c. we have GFDA approval and product in hands. This deserves a re rate

 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
2.7¢
Change
-0.002(6.90%)
Mkt cap ! $20.21M
Open High Low Value Volume
2.8¢ 2.8¢ 2.7¢ $37.38K 1.357M

Buyers (Bids)

No. Vol. Price($)
2 337500 2.6¢
 

Sellers (Offers)

Price($) Vol. No.
2.7¢ 942945 1
View Market Depth
Last trade - 15.55pm 23/06/2025 (20 minute delay) ?
LDX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.